Risk Mitigation Strategies for Critical Raw Materials in Cell Therapy Manufacturing: Addressing Cryopreservation

Time: 10:00 am
day: Day Two


  • Keeping an ATMP manufacturing workflow in a state of control entails risk assessing critical raw materials
  • Cryopreservation is key to address multiple challenges in cell therapy manufacturing
  • DMSO is commonly used as a cryoprotectant, but has risks that can be addressed by DMSO-free formulations